Semin Reprod Med 2006; 24(2): 078-085
DOI: 10.1055/s-2006-939566
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Measurement of Androgens in Women

Frank Z. Stanczyk1
  • 1Professor of Research, Departments of Obstetrics and Gynecology, and Preventive Medicine, University of Southern California, Keck School of Medicine; Women's & Children's Hospital, Los Angeles, California
Further Information

Publication History

Publication Date:
24 April 2006 (online)

ABSTRACT

Much of our knowledge about the physiologic role of androgens in women is based on measurements, primarily in serum, using radioimmunoassay (RIA) methodology that involves purification of the analyte by organic solvent extraction and column chromatography. Although the extraction/chromatographic RIA is highly reliable when properly validated, it is time consuming and costly. For this reason, direct RIA methods were developed. Subsequently, the radioactive marker was replaced by other labels that have been used in direct chemiluminescent, fluorescent, and enzyme immunoassays on autoanalyzers. Although direct immunoassays are simple and rapid, they are seldom thoroughly validated, and generally lack the sensitivity and specificity for reliable measurements of testosterone levels found in postmenopausal serum. In recent years there has been increased use of mass spectrometry assay methods to quantify steroid hormones. These methods are touted to become the gold standard for all steroid hormone measurements. Because urine contains predominantly glucuronidated androgens, multistep procedures are required for the measurement, which is not practical for diagnostic testing. Androgens also can be measured in saliva, but major methodologic problems are associated with the measurements. In addition, there is a misconception that salivary testosterone levels reflect free testosterone levels in serum.

REFERENCES

  • 1 Yalow R S, Berson S A. Assay of plasma insulin in human subjects by immunological methods.  Nature. 1959;  184 1648-1649
  • 2 Yalow R S, Berson S A. Immunoassay of endogenous plasma insulin in man.  J Clin Invest. 1960;  39 1157-1175
  • 3 Odell W D, Ross G T, Rayford R L. RIA of luteinizing hormone in human plasma or serum: physiological studies.  J Clin Invest. 1967;  46 248-255
  • 4 Abraham G E. Sold-phase radioimmunoassay of estradiol-17β.  J Clin Endocrinol Metab. 1969;  29 866-870
  • 5 Abraham G E, Odell W D. Solid-phase radioimmunoassay of serum estradiol-17β: a semi-automated approach. In: Peron FG, Caldwell BV Immunologic Methods in Steroid Determination. New York; Appleton-Century-Crofts 1970: 87-112
  • 6 Stanczyk F Z, Cho M, Endres D B et al.. Limitations of direct estradiol and testosterone immunoassay kits.  Steroids. 2003;  68 1173-1178
  • 7 Taieb J, Mathian B, Millot F et al.. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children.  Clin Chem. 2003;  49 1381-1395
  • 8 Fitzgerald R L, Herold D A. Immunoassays for testosterone in women: better than a guess?.  Clin Chem. 2003;  49 1250-1251
  • 9 Buster J E, Casson P R. DHEA: biology and use in therapeutic intervention. In: Lobo RA, Kelsey J, Marcus R Menopause: Biology and Pathobiology. New York; Academic Press 2000: 625-638
  • 10 Orentreich N, Brind J L, Rizer R L, Vogelman J H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood.  J Clin Endocrinol Metab. 1984;  59 551-555
  • 11 Vermeulen A. Plasma androgens in women.  J Reprod Med. 1998;  43 725-731
  • 12 Goebelsmann U, Arce J J, Thorneycroft I H, Mishell Jr D R. Serum testosterone concentrations in women throughout the menstrual cycle and following hCG administration.  Am J Obstet Gynecol. 1974;  119 445-452
  • 13 Zumoff B, Strain G W, Miller L K, Rosner W. Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women.  J Clin Endocrinol Metab. 1995;  80 1429-1430
  • 14 Vermeulen A, Verdonck L, Kaufman J M. A critical evaluation of simple methods for the estimation of free testosterone in serum.  J Clin Endocrinol Metab. 1999;  84 3666-3672
  • 15 Miller K K, Rosner W, Lee H et al.. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods.  J Clin Endocrinol Metab. 2004;  89 525-533
  • 16 Morley J E, Patrick P, Perry III H M. Evaluation of assays available to measure free testosterone.  Metabolism. 2002;  51 554-559
  • 17 Emadi-Konjin P, Bain J, Bromberg I L. Evaluation of an algorithm for calculation of serum “bioavailable” testosterone (BAT).  Clin Biochem. 2003;  36 591-596
  • 18 Kapoor P, Luttrell B, Williams D. The free androgen index is not valid for adult males.  J Steroid Biochem Mol Biol. 1993;  45 325-326
  • 19 Ekins R. Hirsutism: free and bound testosterone.  Ann Clin Biochem. 1990;  27 91-94
  • 20 Winters S J, Kelley D E, Goodpaster B. The analog free testosterone assay: are the results in men clinically useful?.  Clin Chem. 1998;  44 2178-2182
  • 21 Rosner W. Errors in the measurement of plasma free testosterone.  J Clin Endocrinol Metab. 1997;  82 2014-2015
  • 22 Rosner W. An extraordinary inaccurate assay for free testosterone is still with us [letter].  J Clin Endocrinol Metab. 2001;  86 2903

Frank Z StanczykPh.D. 

Women's & Children's Hospital, Room 1M2

1240 N. Mission Rd., Los Angeles, CA 90033

Email: fstanczyk@socal.rr.com

    >